kabutan

J-Pharma, The Current Fiscal Year's Net Income to Widen

Thu May 14, 2026 4:45 pm JST Earnings

520A J-Pharma Co.,Ltd. 【J-GAAP】

Earnings Report

J-Pharma Co.,Ltd. <520A> [TSE Growth] announced its financial results after the market closed on May 14th (16:45). The net loss (non-consolidated) for the fiscal year ended March 2026 expanded to a loss of 2.46 billion yen (compared to a loss of 1.49 billion yen in the previous period). For the fiscal year ending March 2027, the net loss is expected to be loss of 2.84 billion yen. This will mark the seventh consecutive term of losses.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2026 ー -3,710 -2,636 -2,466 -195.1 0 May 14, 2026 J-GAAP
YoY － 0.0% 0.0% 0.0% 0.0%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2026 Guidance ー -3,861 -2,891 -2,724 -152.8 0 Mar 25, 2026 J-GAAP
Mar, 2026 Results ー -3,710 -2,636 -2,466 -195.1 0 May 14, 2026 J-GAAP
Revision Rate － +3.9% +8.8% +9.5% -27.7%

Current Period Guidance

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2026 ー -3,710 -2,636 -2,466 -195.1 0 May 14, 2026 J-GAAP
Mar, 2027 Guidance ー -2,841 -2,841 -2,842 -158.0 0 May 14, 2026 J-GAAP
YoY － +23.4% -7.8% -15.2% +19.0%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2025 ー -571 -452 -448 -37.6 ー Mar 25, 2026 J-GAAP
Jan - Mar, 2026 ー -1,177 -589 -590 -46.7 ー May 14, 2026 J-GAAP
YoY － － － － －

Related Articles